Researchers from the Medical University of South Carolina in Charleston distributed the survey to 401 practicing pulmonologists who are members of the American College of Chest Physicians.
Only 22% of respondents said pulmonologists bore the leading responsibility for ordering biomarker testing, though 83% said pulmonologists were responsible for ordering an initial diagnostic biopsy.
Characteristics associated with pulmonologists who said they order biomarker testing were longer practice tenure, higher case volumes and participation in a multidisciplinary tumor board, according to the study.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
